Literature DB >> 31637796

Bacterial resistance to antimicrobial peptides.

Milad Abdi1,2, Shiva Mirkalantari2, Nour Amirmozafari2.   

Abstract

Antimicrobial peptides (AMPs) or host defense peptides (HDPs) are vital components of human innate defense system targeting human-related bacteria. Many bacteria have various mechanisms interfering with AMP activity, causing resistance to AMPs. Since AMPs are considered as potential novel antimicrobial drugs, understanding the mechanisms of bacterial resistance to direct killing of AMPs is of great significance. In this review, a comparative overview of bacterial strategies for resistance to direct killing of various AMPs is presented. Such strategies include bacterial cell envelope modification, AMP degradation, sequestration, expelling, and capsule.
© 2019 European Peptide Society and John Wiley & Sons, Ltd.

Entities:  

Keywords:  AMPs; antimicrobial peptides; bacterial resistance; host defense peptides

Mesh：

Substances：

Year:  2019        PMID： 31637796     DOI： 10.1002/psc.3210

Source DB:  PubMed          Journal:  J Pept Sci        ISSN： 1075-2617            Impact factor:   1.905


  9 in total

Review 1.  Indolicidin revisited: biological activity, potential applications and perspectives of an antimicrobial peptide not yet fully explored.

Authors:  Jaqueline Batista Araujo; Guilherme Sastre de Souza; Esteban Nicolas Lorenzon
Journal:  World J Microbiol Biotechnol       Date:  2022-01-12       Impact factor: 3.312

2.  Single-cell stochastic modelling of the action of antimicrobial peptides on bacteria.

Authors:  Hamid Teimouri; Thao N Nguyen; Anatoly B Kolomeisky
Journal:  J R Soc Interface       Date:  2021-09-15       Impact factor: 4.293

3.  The Era of Antimicrobial Peptides: Use of Hepcidins to Prevent or Treat Bacterial Infections and Iron Disorders.

Authors:  Carolina Barroso; Pedro Carvalho; Magda Nunes; José F M Gonçalves; Pedro N S Rodrigues; João V Neves
Journal:  Front Immunol       Date:  2021-09-27       Impact factor: 7.561

Review 4.  The phospholipid membrane compositions of bacterial cells, cancer cell lines and biological samples from cancer patients.

Authors:  Kira L F Hilton; Chandni Manwani; Jessica E Boles; Lisa J White; Sena Ozturk; Michelle D Garrett; Jennifer R Hiscock
Journal:  Chem Sci       Date:  2021-09-28       Impact factor: 9.825

Review 5.  Treatment of Pseudomonas aeruginosa infectious biofilms: Challenges and strategies.

Authors:  Rui Yin; Juanli Cheng; Jingyao Wang; Panxin Li; Jinshui Lin
Journal:  Front Microbiol       Date:  2022-08-26       Impact factor: 6.064

6.  The membrane-active polyaminoisoprenyl compound NV716 re-sensitizes Pseudomonas aeruginosa to antibiotics and reduces bacterial virulence.

Authors:  Gang Wang; Jean-Michel Brunel; Matthias Preusse; Negar Mozaheb; Sven D Willger; Gerald Larrouy-Maumus; Pieter Baatsen; Susanne Häussler; Jean-Michel Bolla; Françoise Van Bambeke
Journal:  Commun Biol       Date:  2022-08-25

Review 7.  Ag-Based Synergistic Antimicrobial Composites. A Critical Review.

Authors:  Ekaterina A Kukushkina; Syed Imdadul Hossain; Maria Chiara Sportelli; Nicoletta Ditaranto; Rosaria Anna Picca; Nicola Cioffi
Journal:  Nanomaterials (Basel)       Date:  2021-06-27       Impact factor: 5.076

8.  Microfluidic Tools for Enhanced Characterization of Therapeutic Stem Cells and Prediction of Their Potential Antimicrobial Secretome.

Authors:  Pasquale Marrazzo; Valeria Pizzuti; Silvia Zia; Azzurra Sargenti; Daniele Gazzola; Barbara Roda; Laura Bonsi; Francesco Alviano
Journal:  Antibiotics (Basel)       Date:  2021-06-22

Review 9.  Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug-resistant Gram-negatives.

Authors:  María Escobar-Salom; Gabriel Torrens; Elena Jordana-Lluch; Antonio Oliver; Carlos Juan
Journal:  Biol Rev Camb Philos Soc       Date:  2022-01-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.